Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | the cathelicidin bovine myeloid antimicrobial peptide 28, BMAP-28, has broad antimicrobial activities and confers protection in animal models of bacterial infection or sepsis. BMAP-28 isomers,i.e. the D-amino acid form D-BMAP-28 and the retro-inverso form RI-BMAP-28, are resistant against GP63 protease activity and act as anti-leishmanial agents against the promastigote and amastigote intracellular Leishmania major lifecycle stages, overview | Leishmania major |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Leishmania major | - |
- |
- |
Leishmania major MHOM/IL/80/Friedlin | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
amastigote | - |
Leishmania major | - |
promastigote | - |
Leishmania major | - |
Synonyms | Comment | Organism |
---|---|---|
GP63 surface metalloprotease | - |
Leishmania major |
General Information | Comment | Organism |
---|---|---|
malfunction | a leishmanolysin knockout strain of Leishmania major Seidman strain lacks the GP63 surface metalloprotease | Leishmania major |
additional information | the cathelicidin bovine myeloid antimicrobial peptide 28, BMAP-28, has broad antimicrobial activities and confers protection in animal models of bacterial infection or sepsis. BMAP-28 isomers,i.e. the D-amino acid form D-BMAP-28 and the retro-inverso form RI-BMAP-28, are resistant against GP63 protease activity and act as anti-leishmanial agents against the promastigote and amastigote intracellular Leishmania major lifecycle stages, overview | Leishmania major |